Non-Opioid Pain Treatment Market Report 2026

Non-Opioid Pain Treatment Market Overview

• Non-Opioid Pain Treatment market size has reached to $55.31 billion in 2025 • Expected to grow to $84.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Rising Incidence Of Sports-Related Injuries Due To Increasing Participation In High-Intensity Sports And Recreational Activities • Market Trend: Transforming Pain Management Through Novel Therapies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Non-Opioid Pain Treatment Market?

A non-opioid pain treatment is therapy or medication used to manage pain without involving opioid drugs. These treatments relieve pain through mechanisms other than opioid receptor activation and include options such as acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), certain antidepressants, and anticonvulsants for nerve pain, as well as physical therapies such as physiotherapy, exercise, heat or cold therapy, and massage. The main product types of non-opioid pain treatment are medical cannabis, menthol-containing, omega-3 fatty acid-containing, botulinum toxins, and capsaicin-derived. Medical cannabis refers to the therapeutic use of the cannabis plant or its extracts to alleviate symptoms or manage various health conditions. The drug classes used in these treatments include nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, local anesthetics, antidepressants, anticonvulsants, corticosteroids, and others, administered through oral, topical, injectable, and other means. These are distributed through hospital pharmacies, retail pharmacies, drugstores, and mail-order pharmacies. Common applications encompass orthopedic and musculoskeletal pain, postoperative pain, cancer-related pain, neuropathic pain, and others.

What Is The Non-Opioid Pain Treatment Market Growth Forecast?

The non-opioid pain treatment market size is expected to see strong growth in the next few years. It will grow to $84.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to development of innovative non-opioid therapeutics, expansion of digital health monitoring and telemedicine for pain, growing adoption of combination therapies, increasing government initiatives for pain management, rising investment in personalized pain care and alternative therapies. Major trends in the forecast period include rising adoption of non-opioid pain management therapies, increased use of medical cannabis and omega-3 fatty acid supplements, growth in topical and injectable pain relief products, expansion of pain management services in hospitals and clinics, integration of non-pharmacological therapies like acupuncture and tens.

Global Non-Opioid Pain Treatment Market Segmentation

1) By Product: Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products 2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes 3) By Route Of Administration: Oral, Topical, Injectable, Other Route Of Administrations 4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies 5) By Application: Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications Subsegments: 1) By Medical Cannabis: Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products 2) By Menthol Containing: Topical Creams, Gels, Sprays 3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements, Algae Derived Supplements, Krill Oil Derived Supplements 4) By Botulinum Toxins: Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A 5) By Capsaicin Derived: Low Concentration Creams, High Concentration Patches, Nasal Sprays 6) By Other Products: Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices

What Is The Driver Of The Non-Opioid Pain Treatment Market?

The rising incidence of sports-related injuries is expected to propel the growth of the non-opioid pain treatment market going forward. Sports-related injuries are physical injuries that occur during or as a result of sports or exercise activities. The rising incidence of sports-related injuries is due to increasing participation in high-intensity sports and recreational activities, which exposes athletes to a greater risk of physical trauma. Non-opioid pain treatment is useful for sports-related injuries by providing effective pain relief and inflammation reduction without the risks associated with opioid use, supporting faster recovery, improved function, and safer long-term management. For instance, in October 2024, according to the Howden Group Holdings Ltd, a UK-based insurance intermediary company, in the 2023-24 football season, Europe’s top five leagues recorded 4,123 injuries, marking a 4% increase compared to the previous season. Therefore, the rising incidence of sports-related injuries is driving the growth of the non-opioid pain treatment industry.

Key Players In The Global Non-Opioid Pain Treatment Market

Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy's Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA

Global Non-Opioid Pain Treatment Market Trends and Insights

Major companies operating in the non-opioid pain treatment market are focusing on innovations in drug formulations, such as non-opioid oral treatment to deliver effective pain relief and minimize the risks linked to opioid use and addiction. Non-opioid oral treatment refers to pain-relieving drugs administered orally that do not include opioids and function through alternative mechanisms, such as reducing inflammation, modulating nerve signals, or acting on specific receptors, to manage pain without the addiction potential or respiratory depression often associated with opioids. For instance, in July 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, introduced JOURNAVX, a first-in-class non-opioid therapy that provides effective relief for moderate-to-severe acute pain. This cutting-edge non-opioid treatment employs targeted modulation of pain pathways, offers a favorable safety profile, and delivers a rapid onset of action, enabling strong pain control, reduced dependency potential, and enhanced patient well-being. It ensures focused pain management, lowers addiction risks, and supports faster recovery and better quality of life for patients experiencing acute pain.

What Are Latest Mergers And Acquisitions In The Non-Opioid Pain Treatment Market?

In May 2025, Eli Lilly and Company, a US-based pharmaceutical company, acquired SiteOne Therapeutics Inc. for an undisclosed amount. With this acquisition, Eli Lilly and Company aims to expand its neuroscience pipeline by developing and commercializing STC-004, a non-opioid Nav1.8 inhibitor, to provide a safer, effective treatment for chronic pain without the risks of addiction. SiteOne Therapeutics Inc. is a US-based pharmaceutical company that offers non-opioid pain treatments.

Regional Insights

North America was the largest region in the non-opioid pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Non-Opioid Pain Treatment Market?

The non-opioid pain treatment market consists of revenues earned by entities by providing services such as physical therapy services, cognitive and behavioral therapies, and interventional pain management. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-opioid pain treatment market also includes sales of antidepressants, anticonvulsants, and acupuncture kits. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Non-Opioid Pain Treatment Market Report 2026?

The non-opioid pain treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-opioid pain treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.